Backward supply integration to trigger valuation re-rating post demerger: InGovern on UPL Global
New Delhi, March 16
Proxy Firm InGovern notes that UPL's integrated crop protection platform - UPL Global emerges as among the largest listed global crop protection pure-plays by revenue, leveraging consolidated global and Indian scale in herbicides, insecticides, fungicides, and biosolutions.
It highlighted UPL Global's backend moat that assured supply from UPL Limited's Superform manufacturing, R&D integration, and specialty chemicals. This ensures cost reliability and supply chain resilience that its peers lack.
The report added "UPL Limited's strategic reorganization represents a definitive move to unlock trapped value. It provides shareholders with direct, proportional ownership of a global crop protection leader while maintaining the manufacturing moat that drives margin sustainability."
Proxy advisory firm InGovern said the proposed reorganisation is the "fastest and cleanest" route compared with IPOs or vertical splits, as it consolidates the Crop Protection business under a single listed entity without dilution, hidden minorities or lost linkages. The report said pure-play platforms would allow independent capex and strategy and help the company access specialised sector funds. It added that recent Indian demergers demonstrate that simplified pure-play structures consistently generate superior shareholder returns by eliminating conglomerate discounts and enabling focused strategies.
On governance, InGovern said the pure-play entities would retain about 50% independent directors with no board overlap between the holding company and the pure-play unit, reducing conflicts of interest. It added that promoter family entity Upswing Trust would shift from roughly a 37% stake in UPL Ltd to a 16.78% direct public stake in UPL Global, with only one non-executive director nomination right, preserving board independence at above 50%. The promoter group has also voluntarily agreed to an 18-month lock-in on its UPL Global stake post-listing, exceeding regulatory minimums.
The regulatory process for the scheme of arrangement is expected to take 12-15 months, with a record date for the demerger set after NCLT approval, which is expected in the second quarter of fiscal 2027.
— ANI
Reader Comments
The backend manufacturing moat is the real story here. In the current global scenario, having assured supply from India is a massive competitive advantage. Hope this leads to better valuations for a true Indian MNC.
Good to see the governance focus - 50% independent directors and no board overlap is crucial. Promoters reducing stake and agreeing to a lock-in shows they are serious about creating long-term shareholder value, not just a quick exit.
The timeline is quite long - 12-15 months for regulatory process and listing expected only in FY27. While the structure seems sound, a lot can change in the agrochemicals market by then. Investors will need patience.
As a shareholder, I welcome this. The 'simplified pure-play structures' point is key. Look at the rerating we saw in other Indian demergers. This should make UPL Global much easier to understand and value for global funds.
Respectfully, while the report is optimistic, I hope the execution is flawless. Demergers can be complex, and maintaining the 'supply chain resilience' and cost benefits post-split will be the real challenge. The theory is good, but let's see it in practice.
We welcome thoughtful discussions from our readers. Please keep comments respectful and on-topic.